PowerCycling PCX Elongated Thermoelectric Coolers Speed up PCR Testing Reports Laird Thermal Systems

Elongated Thermoelectric Coolers: Thermal Cycling devices used for Real-Time PCR utilize thermoelectric technology to precisely manage temperature set points and ramp rates, enabling amplification of DNA segments.

To improve temperature precision control in PCR devices, Laird Thermal Systems has developed an elongated series of PowerCycling PCX thermoelectric coolers. Utilizing proprietary processes and a unique module construction, the PCX Elongated Series provides high reliability and a minimal temperature gradient for PCR applications resulting in greater throughput and faster test results.

PCR requires a high number of thermal cycles to create millions of DNA strands used for medical diagnosis. Each thermal cycle consists of three steps, where the first separates the DNA strands at a high temperature of 95°C.

The second step is a cool down to a melt temperature between 50 to 65°C where the biomarkers will bond to the DNA and the third stage increases the temperature to 72°C to sequence a copy of the DNA. Thermoelectric coolers are installed under the PCR wells to precisely manage these temperature setpoints to within ±0.5ºC.

Determining the optimum melt temperature of each thermal cycling stage is often a time-consuming process for laboratory technicians. By creating more temperature zones on the PCR tray, the optimal melt temp can be found.

The new PCX Elongated series allows for more narrow temperature zones than standard thermoelectric coolers, providing more precise temperature control across the tray, making it easier for technicians to determine the right temperature.

“Elongated thermoelectric coolers are extremely challenging to manufacture due to the bowing effect that can occur with longer parts. The longer the length is to the width, the more likely the ceramics tend to bow, which can be challenging to manufacture”, said Andrew Dereka, Product Director at Laird Thermal Systems. “Through proprietary process controls and advanced semiconductor materials, our PCX Elongated thermoelectric cooler eliminates the impact of this effect to provide a highly reliable part for Real-Time PCR.”

The PowerCycling PCX Series features a unique robust construction with a thermally conductive “soft layer” that absorbs the mechanically induced stresses caused by thermal cycling applications. This series has been tested to meet the latest PCR industry standards without degrading in performance.

Access PowerCycling PCX Series datasheets or learn more about thermal management for PCR in our application note.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version